BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4543703)

  • 1. Prevention of diuretic-induced electrolyte disturbances by amiloride in patients with ascites due to cirrhosis of the liver.
    Bianchi Porro G; Petrillo M
    Acta Cardiol; 1973; ():Suppl 17:307-1. PubMed ID: 4543703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G; Lazzaroni M; Petrillo M
    Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
    Senewiratne B; Sherlock S
    Lancet; 1968 Jan; 1(7534):120-2. PubMed ID: 4169604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of amiloride (MK 870) on water and electrolyte metabolism in ascitic cirrhotics].
    Vesin P; Roberti A; Viguie R
    Schweiz Med Wochenschr; 1969 Jan; 99(1):21-6. PubMed ID: 5790153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A; Bancons J; Dubarry JJ
    Bord Med; 1972 Oct; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].
    Meyer P; Milliez P
    Nouv Presse Med; 1972 Sep; 1(32):2121-2. PubMed ID: 5082245
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuretic drug therapy of edema.
    Perez-Stable EC; Materson BJ
    Med Clin North Am; 1971 Mar; 55(2):359-72. PubMed ID: 4926056
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of amiloride on metabolic alkalosis and hypokalaemia after cardiopulmonary bypass surgery.
    Hocking MA; Bain WH
    Br Heart J; 1974 Jun; 36(6):597-602. PubMed ID: 4851604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
    Boschetti E; Dottorini M; Bentivoglio M; Losito A; Grassi V; Muiesan G
    Clin Ter; 1977 Mar; 80(6):530-6. PubMed ID: 862353
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of amiloride hydrochloride in the correction of hypokalaemic alkalosis induced by diuretics.
    Antcliff AC; Beevers DG; Hamilton M; Harpur JE
    Postgrad Med J; 1971 Oct; 47(552):644-7. PubMed ID: 5158837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrolyte depletion in the complications of diuretic therapy in hepatic cirrhosis.
    Shah CP; Shah NV; Acharya PT; Shukla DN
    J Assoc Physicians India; 1968 Sep; 16(9):639-43. PubMed ID: 5711924
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of metolazone in the treatment of ascites due to liver disease.
    Hillenbrand P; Sherlock S
    Br Med J; 1971 Oct; 4(5782):266-70. PubMed ID: 5123909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
    Ram CV; Holland OB; Kaplan NM
    J Clin Pharmacol; 1981; 21(11):484-7. PubMed ID: 7334141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
    Schwartz M; Fodor O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(3):219-25. PubMed ID: 770
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorders of water-electrolyte metabolism associated with decompensated cirrhosis. The danger of various therapeutic drugs].
    Bodin F; Liguory C; Capelle P; Conte M
    Sem Hop; 1968 May; 44(23):1591-8. PubMed ID: 4302321
    [No Abstract]   [Full Text] [Related]  

  • 18. Bumetanide in the treatment of hepatic ascites. A short and long-term study.
    Ring-Larsen H
    Acta Med Scand; 1974 May; 195(5):411-4. PubMed ID: 4830058
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term studies with the new potassium-sparing diuretic, amiloride ('MK-870').
    Heffernan AG; Counihan TB
    Ir J Med Sci; 1969 Jan; 8(1):3-16. PubMed ID: 5807514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of ascites in cirrhosis of the liver].
    Del Solar V; Lobo G; Varela N; Lehmann C
    Rev Med Chil; 1965 Sep; 93(9):549-56. PubMed ID: 5888085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.